BETAHISTINE-ZP betahistine dihydrochloride 16mg tablets blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

betahistine dihydrochloride, Quantity: 16 mg

MAH:

Medis Pharma Pty Ltd

INN:

betahistine dihydrochloride

pharmaceutical_form:

Tablet

composition:

Excipient Ingredients: crospovidone; lactose monohydrate; povidone; stearic acid; colloidal anhydrous silica; microcrystalline cellulose

administration_route:

Oral

units_in_package:

100 tablets, 25 tablets, 10 tablets

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

leaflet_short:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B16 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2015-11-10